Insider Transactions in Q1 2024 at Bio Atla, Inc. (BCAB)
Insider Transaction List (Q1 2024)
| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
Mar 31
2024
|
Eric Sievers Chief Medical Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
572
-0.27%
|
$1,716
$3.44 P/Share
|
|
Mar 31
2024
|
Scott Andrew Smith |
SELL
Payment of exercise price or tax liability
|
Direct |
2,181
-0.74%
|
$6,543
$3.44 P/Share
|
|
Feb 29
2024
|
Scott Andrew Smith |
SELL
Payment of exercise price or tax liability
|
Direct |
2,181
-0.73%
|
$4,362
$2.7 P/Share
|
|
Feb 29
2024
|
Eric Sievers Chief Medical Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
572
-0.27%
|
$1,144
$2.7 P/Share
|
|
Feb 16
2024
|
Jay M Phd Short Chief Executive Officer |
BUY
Grant, award, or other acquisition
|
Direct |
417,000
+18.34%
|
-
|
|
Feb 15
2024
|
Eric Sievers Chief Medical Officer |
BUY
Grant, award, or other acquisition
|
Direct |
122,000
+36.57%
|
-
|
|
Feb 15
2024
|
Richard A Waldron Chief Financial Officer |
BUY
Grant, award, or other acquisition
|
Direct |
106,000
+31.46%
|
-
|
|
Feb 15
2024
|
Christian Vasquez Officer |
BUY
Grant, award, or other acquisition
|
Direct |
70,000
+27.38%
|
-
|
|
Jan 31
2024
|
Eric Sievers Chief Medical Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
657
-0.73%
|
$657
$1.92 P/Share
|
|
Jan 31
2024
|
Scott Andrew Smith |
SELL
Payment of exercise price or tax liability
|
Direct |
2,181
-0.73%
|
$2,181
$1.92 P/Share
|